Roots Analysis has announced the addition of “Biosensors Market: Focus on Drug Discovery and Drug Development, 2022 - 2035” report to its list of offerings.

Inrecent years, the use of biosensors in drug discovery has been on the rise,driven by several technological advancements and the growing demand forinexpensive and effective techniques for analyzing potential drug candidates

Roots Analysis has announced theaddition of “Biosensors Market: Focus on DrugDiscovery and Drug Development, 2022 - 2035” report to its list of offerings.

A number of drug developersare already using novel biosensors for various drug discovery applications toaddress the concerns associated with high rate of failures of drug developmentprograms and requirement of high capital investments. As the adoption ofbiosensors, specifically for drug discovery, increases amongst innovators inthe pharma and biopharma industry, lucrative opportunities are expected to becreated for players engaged in the biosensors for drug discovery market. 

GetDetailed Report:

KeyMarket Insights

Currently,more than 80 biosensors are being developed by various stakeholders, across theworld

Majority of the biosensors(64%) engaged in this domain are optical biosensors, followed byelectrochemical biosensors (25%), quartz crystal microbalance biosensors (5%)and thermal biosensors (5%). Close to 95% of the biosensors are used for leadidentification step in drug discovery. Further, 15% of the biosensors claim tosupport all the steps in drug discovery.

OverUSD 1.2 billion invested in various domain focused initiatives, since 2018

Specifically, in 2021,industry players raised close to USD 600 billion. In addition, majority of thecompanies (66%) primarily received funding through venture capital rounds.Further, around 60% of the total funding instances were reported by playersheadquartered in the US.

Inrecent years, several global events related to biosensors in drug discoverywere organized

Majority of the eventsrelated to biosensors in drug discovery were organized in Europe (45%). It isworth highlighting that the main agenda of these events was to discuss thedevelopment and challenges associated with the biosensors in drug discoverydomain.

Requestfor Customization @ Biosensors Market is projected to growat CAGR of 9% by 2035

370+patents related to biosensors in drug discovery have been granted / filedbetween 2018-2022

R&D activity related tobiosensors in drug discovery is largely concentrated in North America,considering the fact that 70% of the total number of patents were filed in thisregion. In addition, most of the patents in this domain are granted patents(55%), followed by patent applications (44%).

NorthAmerica and Europe are anticipated to capture over 70% of the market share, by2035

In addition, the market inAsia Pacific is likely to grow at a relatively faster pace (10%) in the longterm. Further, in 2035, biosensors market for drug discovery applications foracademic / research institutes is expected to capture the majority share (~60%)of the total market.   

KeyQuestions Answered

·       Who are the key players engaged in thebiosensors in drug discovery market?

·       What is the relative competitiveness ofdifferent biosensors being developed for drug discovery applications?

·       What are the key agenda items being discussedin various global events / conferences related to biosensors in drug discovery?

·       What is the focus area of the ongoingresearch activity related to biosensors in drug discovery?

·       How is the intellectual property landscapefor biosensors in drug discovery likely to evolve in the foreseen future?

·       What are the factors that are likely toinfluence the evolution of this market?

·       How is the current and future marketopportunity likely to be distributed across key segments?

Requestfor Sample:

Thefinancial opportunity within the Biosensors and taste assessment services andtechnologies market has been analyzed across the following segments:

Typeof Biosensor

·       Optical

·       Electrochemical

·       Thermal

·       Others

Typeof End User

·       Academic / Research Institutes

·       Industry Players

KeyGeographical Regions

·       North America

·       Europe

·       Asia-Pacific

·       Latin America

·       MENA

·       Rest of the World

Thereport features inputs from eminent industry stakeholders, according to whom,continuous growth of biosensors market for drug discovery applications isprimarily driven by the increasing adoption for such products. The reportincludes detailed transcripts of discussions held with the following experts:

·       Bill Rader (Chief Executive Officer, EfferentLabs)

·       Anne Marie Quinn (Chief Executive Officer,Montana Molecular)

·       Laurent Sabbagh (Associate Director and Headof Biology, Domain Therapeutics)

Theresearch includes profiles of key players (listed below); each profile featuresa brief overview of the company, details related to its biosensor productportfolio, recent developments and an informed future outlook.

·       Agilent Technologies

·       Axion Biosciences

·       BioNavigations

·       Creoptix 

·       Cytiva

·       Dynamic Biosensors

·       Malvern Panalytical

·       Microvacuum

·       Sartorius

·       Tempo Bioscience

Inquirybefore Purchasing:


ReadOur Latest Press Release:






Visitfor More Insights:

ReadOur Latest Press Release:

LatestBlogs On Healthcare Industry:


OurService Portfolio: Pipeline Tracking | Publication Analysis | Investment Analysis | Market Assessment | Competitive Profiling | Commercial Strategy and BusinessDevelopment


AboutRoots Analysis

RootsAnalysis isone of the fastest growing market research companies, sharing fresh andindependent perspectives in the bio-pharmaceutical industry. The in-depthresearch, analysis and insights are driven by an experienced leadership teamwhich has gained many years of significant experience in this sector.


RootsAnalysis Private Limited


+1(415) 800 3415